In the Personalised Oncology division clinicians and scientists are working together to reduce the impact of cancer in our community.

Our researchers use tumour samples and clinical data to better understand the characteristics of individual patients’ genetic make-up and the genetics of their cancer. We aim to use this insight to progress personalised strategies for the prevention, detection, diagnosis and treatment of cancer.

Health impact

Cancers: bowel cancer, brain cancer, breast cancer, leukaemia, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, rare cancers, stomach cancer

Immune health and infection: autoinflammatory diseases, chronic infections, Crohn’s disease, inflammatory bowel disease, influenza, rheumatoid arthritis

Development and ageing: multiple sclerosis, regenerative medicine

Other: pneumococcal infections, sickle cell anaemia, immunotherapy, targeted therapy

Division news

• New finding could ‘pause and rewind’ lung cancer
• Cancer blood test trialed to prevent unnecessary chemo
• Odd one out: protein goes against the family to prevent cancer
• Australian researchers contribute to a new blood test for early detection of multiple cancers

Division heads

Professor Peter Gibbs

Associate Professor Marie-Liesse Labat

Lab heads

Dr Sarah Best

Professor Tony Burgess

Associate Professor Tracy Putoczki

Associate Professor Oliver Sieber

Division coordinator

Dr Sabine Kelly